1. Home
  2. IPSC

as 10-07-2025 3:30pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Founded: 2019 Country:
United States
United States
Employees: N/A City: PHILADELPHIA
Market Cap: 43.2M IPO Year: 2021
Target Price: $3.33 AVG Volume (30 days): 486.6K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.27 EPS Growth: N/A
52 Week Low/High: $0.34 - $1.83 Next Earning Date: 11-04-2025
Revenue: $114,128,000 Revenue Growth: 5491.77%
Revenue Growth (this year): 1589.94% Revenue Growth (next year): N/A

Stock Insider Trading Activity of Century Therapeutics Inc. (IPSC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Pfeiffenberger Brent IPSC President and CEO Sep 8 '25 Sell $0.50 488 $244.00 3,268,909
Russotti Gregory IPSC See Remarks Sep 8 '25 Sell $0.50 539 $269.50 391,508
Carr Douglas IPSC SVP Finance & Operations Sep 8 '25 Sell $0.50 263 $131.50 405,423

Share on Social Networks: